Back to Speakers
Dennis Bastas is the Executive Chairman and CEO of the Arrotex Australia Group of companies and Chairman of Juno Pharmaceuticals. In 2015, Dennis acquired the Arrow business, in partnership with Strides Pharmaceuticals, from Aspen Pharmaceuticals. After buying out the Strides ownership in 2019, he merged the business with Apotex Australia to form Arrotex Pharmaceuticals. Prior to this, Dennis founded Ascent Pharmaceuticals and as CEO went on to build a successful Australian and Asian generic pharmaceutical company which was ultimately sold to Actavis Pharmaceuticals. Dennis also developed the Central Healthcare group of companies in 2010, which he sold to Sigma Pharmaceuticals in 2014. Dennis is also the major shareholder and Chairman of myDNA, a world leading pharmacogenomic and health genomic platform technology.
Chairman & Group CEO, Arrotex Australia Group
Alan Russell Oration: Global search for innovation– learnings for Community Pharmacy in Australia
Thursday 19 March, 12.15pm –1.00pm
Proudly sponsored by:
© 2022 APP Conference. All Rights Reserved.
The 2022 Australian Pharmacy Professional Conference is proudly sponsored by:
SPONSORSHIP & TRADE
(c) 2021 APP Conference 2022. All Rights Reserved.
The Pharmacy Guild of Australia
OFFICIAL EVENT PARTNER
07 3831 9246
07 3831 3788
TERMS AND CONDITIONS
APP Sand 1
APP OCEAN 3
APP OCEAN 2
UPDATE YOUR DETAILS
SUBSCRIBE TO ENEWS